Health Catalyst, Inc. $HCAT Shares Purchased by Acadian Asset Management LLC

Acadian Asset Management LLC raised its stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 88.8% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 930,229 shares of the company’s stock after purchasing an additional 437,536 shares during the period. Acadian Asset Management LLC owned 1.34% of Health Catalyst worth $4,211,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of HCAT. First Light Asset Management LLC increased its position in Health Catalyst by 99.1% during the first quarter. First Light Asset Management LLC now owns 10,436,807 shares of the company’s stock worth $47,279,000 after purchasing an additional 5,195,686 shares during the last quarter. Nepsis Inc. increased its position in Health Catalyst by 2,072.1% during the first quarter. Nepsis Inc. now owns 2,090,812 shares of the company’s stock worth $9,471,000 after purchasing an additional 1,994,555 shares during the last quarter. Whetstone Capital Advisors LLC acquired a new position in Health Catalyst during the first quarter worth approximately $7,724,000. Nuveen LLC acquired a new position in Health Catalyst during the first quarter worth approximately $2,674,000. Finally, Connor Clark & Lunn Investment Management Ltd. increased its position in Health Catalyst by 172.6% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 694,361 shares of the company’s stock worth $3,145,000 after purchasing an additional 439,599 shares during the last quarter. Institutional investors and hedge funds own 85.00% of the company’s stock.

Health Catalyst Price Performance

HCAT opened at $3.13 on Monday. The company has a fifty day simple moving average of $3.51 and a 200 day simple moving average of $3.86. The firm has a market cap of $220.26 million, a price-to-earnings ratio of -2.07 and a beta of 1.53. Health Catalyst, Inc. has a twelve month low of $2.52 and a twelve month high of $9.24. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.44.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on HCAT shares. Cantor Fitzgerald reissued a “neutral” rating and issued a $4.00 price objective (down previously from $9.00) on shares of Health Catalyst in a research report on Friday, August 8th. Wells Fargo & Company dropped their price objective on shares of Health Catalyst from $10.00 to $6.00 and set an “overweight” rating for the company in a research report on Monday, August 11th. Evercore ISI increased their price objective on shares of Health Catalyst from $3.00 to $4.00 and gave the stock an “in-line” rating in a research report on Thursday, August 28th. Canaccord Genuity Group dropped their price objective on shares of Health Catalyst from $9.00 to $5.00 and set a “buy” rating for the company in a research report on Friday, August 29th. Finally, Summit Redstone set a $5.00 price objective on shares of Health Catalyst in a research report on Friday, August 29th. Three investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, Health Catalyst currently has an average rating of “Hold” and an average price target of $4.73.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.